Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Food Recall Warning - Bowen Island Brewing brand beer recalled due to cans with defective seams that may have sharp metal sticking out from the rim


Product photos are available at http://www.inspection.gc.ca/eng/1535506595389/1535506597533

OTTAWA, Aug. 28, 2018 /CNW/ - Northam Beverages Ltd. is recalling Bowen Island Brewing brand beer from the marketplace due to cans with defective seams that may have sharp metal sticking out from the rim. Consumers should not consume the recalled products described below.

The following products have been sold in Alberta and British Columbia.

Recalled products

 

Brand

Product

Size

UPC

Codes

Bowen Island Brewing

Artisan IPA (India Pale Ale)

6 x 355 mL

6 26990 09858 4

All codes starting with L18207, L18187, or L18215

Bowen Island Brewing

West Coast Lager

6 x 355 mL

6 26990 05123 7

All codes starting with L18207

 

What you should do

Check to see if you have recalled product in your home. Recalled products should be thrown out or returned to the store where they were purchased.

Background

This recall was triggered by the company. The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Injuries

There have been reported injuries associated with these products.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 07:15
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") , InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability, and speed challenges, together with ImmunoPrecise...

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...

at 07:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the...

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...



News published on and distributed by: